Validation of myStrength's Macropersonalization Engine

NCT05417178 | Unknown

• 1 other identifier: PAG_Macro 2022
• Study Type: observational
• Target: 200
• Locations: 1 country
• Sites: 1

Brief Summary

This is a study to validate myStrength's macropersonalization algorithm. Specifically, the study seeks to answer: Does myStrength's macropersonalization algorithm match what a clinician would offer as a diagnosis following an expert assessment? Participants will be treatment-seeking adults, ages 18 to 65, recruited from an evidence-based group psychotherapy practice. Participants will be asked to complete myStrength onboarding and a clinician-conducted initial assessment. Inter-rater reliability will be assessed to determine the consistency between myStrength and clinician in primary focus area of digital program.

Conditions

Depression, Anxiety; Trauma

Keywords

Sleep; Digital Therapy

Outcome Measures

Primary Outcomes (1)

• Inter-rater reliability on primary focus area

  Inter-rater reliability between myStrength macropersonalization engine and expert clinical recommendation for an individual's primary focus

  Upon completion of initial assessments by subject and clinician within 30 days of signing informed consent.

Interventions

myStrength Macropersonalization Enginge OTHER

An onboarding process that utilizes the PHQ-9, GAD-7, and WHO-5 that leads to a user of the digital program's clinical focus and primary, secondary, and tertiary intervention recommendations.

Eligibility Criteria

• Age: 18 Years - 85 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Participants will be individuals seeking initial evaluation and treatment at the Pacific Anxiety Group.

You may qualify if:

• Aged 18 to 85, inclusive
• Able to read, write, and speak in English
• Has access to the Internet to complete study procedures
• Currently engaged in therapy or has schedule an initial appointment with the Pacific Anxiety Group

You may not qualify if:

• None

Sponsors & Collaborators

• Teladoc Health: lead

Study Sites (1)

Pacific Anxiety Group

Menlo Park, California, 94025, United States

RECRUITING

MeSH Terms

Conditions

Depression; Anxiety Disorders; Wounds and Injuries

Condition Hierarchy (Ancestors)

Behavioral Symptoms; Behavior; Mental Disorders

Study Officials

• Bobbie James, MStat

  Teladoc Health

  STUDY DIRECTOR

Central Study Contacts

Jessica Yu, PhD

CONTACT

650-804-8434; jessica.yu@teladochealth.com

Sravanthi Dama, MD, MPH

CONTACT

347-645-0140; sravanthia.dama@teladochealth.com

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: PROSPECTIVE
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 22, 2022
• First Posted: June 14, 2022
• Study Start: May 1, 2022
• Primary Completion: December 31, 2022
• Study Completion: March 31, 2023
• Last Updated: June 14, 2022

Record last verified: 2022-06

Locations

US (1)